UCL Division of Biosciences


Antibodies: Sequence, Structure and Designing Therapeutics

A two day course that will give you an understanding of antibody research. From bioinformatics to human drug trials including the legal challenges involved.

UCL, Bloomsbury Campus London

Date: 10th & 11th June 2024

To apply for a place on this course, please send your CV to: biosciences.cpd@ucl.ac.uk


Course leaders

Professor Andrew Martin, Division of Biosciences UCL
Professor Kerry Chester, UCL Cancer Institute

It is estimated that antibodies now represent around one third of all drugs in development.  This course consists of lectures and workshops that will teach you how to search for antibodies using powerful bioinformatic software, how to interpret the findings, and how the results are used by Professor Chester to design therapeutics at the UCL Cancer Institute and their use in human drug trials.
Suitable for all scientific disciplines

approved by RSB for 48 credit points